A detailed history of Avalon Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Avalon Trust CO holds 350 shares of AZN stock, worth $25,753. This represents 0.0% of its overall portfolio holdings.

Number of Shares
350
Previous 1,550 77.42%
Holding current value
$25,753
Previous $121 Million 81.01%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

SELL
$63.2 - $79.58 $75,840 - $95,496
-1,200 Reduced 77.42%
350 $22.9 Million
Q3 2024

Nov 13, 2024

SELL
$76.67 - $87.62 $92,004 - $105,144
-1,200 Reduced 43.64%
1,550 $121 Million
Q1 2024

May 07, 2024

SELL
$61.03 - $69.57 $48,824 - $55,655
-800 Reduced 22.54%
2,750 $186 Million
Q4 2023

Feb 06, 2024

SELL
$61.89 - $69.28 $10,830 - $12,124
-175 Reduced 4.7%
3,550 $239 Million
Q1 2023

May 11, 2023

BUY
$63.15 - $71.6 $235,233 - $266,710
3,725 New
3,725 $259 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $228B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Avalon Trust CO Portfolio

Follow Avalon Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Trust CO with notifications on news.